Skip to main content

Table 2 Univariable logistic regression analysis of variables associated with poor functional outcome

From: Association between low-density cholesterol change and outcomes in acute ischemic stroke patients who underwent reperfusion therapy

Variable

Unadjusted odds ratio (95% confidence interval)

p-value

Age

1.04 (1.03, 1.06)

<0.001

Male

0.51 (0.35, 0.77)

0.001

Hypertension

1.29 (0.87, 1.91)

0.204

Diabetes

1.30 (0.82, 2.08)

0.268

hyperlipemia

1.04 (0.51, 2.14)

0.912

Atrial fibrillation

2.34 (1.57, 3.48)

<0.001

Valvular heart diseases

1.32 (0.78, 2.23)

0.302

coronary heart diseases

1.23 (0.71, 2.16)

0.460

Statin use before admission

1.16 (0.59, 2.31)

0.666

Previous stroke

1.50 (0.74, 3.04)

0.265

Current smoking

0.60 (0.38, 0.93)

0.021

Alcohol consumption

0.59 (0.38, 0.93)

0.022

Baseline NIHSS score

1.17 (1.12, 1.21)

<0.001

HDL upon admission

1.28 (0.78, 2.10)

0.334

TG upon admission

0.92 (0.78, 1.09)

0.333

TC upon admission

1.00 (0.85, 1.19)

0.966

Serum glucose

1.08 (1.00, 1.17)

0.038

White blood cell

1.04 (0.98, 1.11)

0.208

TOAST classification

  

Large-artery Atherosclerosis

Reference

 

Cardio-embolism

1.75 (1.11, 2.76)

0.017

Lacunar

0.20 (0.08, 0.53)

0.001

Other

0.63 (0.20, 1.98)

0.431

Undetermined

1.11 (0.60, 2.05)

0.748

Reperfusion therapy method

  

thrombolysis only

Reference

 

thrombectomy only

1.76 (1.12, 2.77)

0.015

thrombolysis and thrombectomy

1.22 (0.72, 2.09)

0.463

Statin use during hospitalization

0.98 (0.67, 1.48)

0.995

Interval between stroke onset and emergency department

1.05 (0.89, 1.24)

0.546

Interval between stroke onset and admission measurement of LDL-C

1.04 (0.89, 1.21)

0.616

Interval between admission and follow-up measurement of LDL-C

1.06 (1.01, 1.12)

0.023

  1. NIHSS National Institutes of Health Stroke Scale, TOAST the Trial of Org 10,172 in Acute Stroke Treatment